journal
MENU ▼
Read by QxMD icon Read
search

Biotechnology Healthcare

journal
https://www.readbyqxmd.com/read/23267286/new-fdasia-legislation-will-help-biotechs
#1
Susan Worley
The need to invest in the regulatory environment to support biotechnology innovation is urgent, says Jim Greenwood, president and CEO, Biotechnology Industry Organization.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267285/a-truer-way-to-measure-value-of-diagnostic-tests
#2
Bob Carlson
Helping payers track advanced diagnostics is a must in a health reform environment.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267284/as-rems-requirements-simplify-participants-need-to-catch-up
#3
John Carroll
No abstract text is available yet for this article.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267283/antibody-drug-conjugates-where-the-action-is-adcs-the-new-frontier
#4
Bob Carlson
Next generation antibody-drug conjugates, like T-DM1, are meant to kill the cancer - not the patient.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267282/ms-treatment-is-on-the-cusp-of-something-big-on-the-cusp-of-something-big
#5
Susan Worley
For so long, multiple sclerosis has frustrated physicians and patients. With bold new treatments on the way, payers are thinking about tighter management. Formal treatment guidelines would help. Bio-markers could also sort out the 'right-drug, right-patient' conundrum.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267281/can-we-afford-the-war-on-cancer
#6
Ed Silverman
Immunotherapy vaccines could extend survival in a handful of cancers. But personalizing treatment, payers argue, is not sustainable. Where should the line be drawn?
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267280/to-heal-the-body-get-into-the-patient-s-head-motivational-interviewing-to-improve-adherence
#7
Jack McCain
For patients, poor adherence to biologics can increase risks of morbidity and mortality. For payers, it means money down the drain. Here's a tool that proponents say can help change patient behavior.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267279/the-day-of-the-passive-purchaser-is-over-building-a-smarter-employer
#8
Michael D Dalzell
In a system of healthcare financing that largely doesn't work for specialty drugs, the Midwest Business Group on Health is leading an ambitious initiative to educate and empower employers. The project's scope and potential outcomes are unprecedented.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267278/biologics-clinical-trials-research-and-fda-actions
#9
Michael D Dalzell
No abstract text is available yet for this article.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267277/defined-contribution-and-alternative-care-meet-personalized-medicine
#10
F Randy Vogenberg
No abstract text is available yet for this article.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23267276/choosing-health
#11
Katherine T Adams
No abstract text is available yet for this article.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23091435/employers-target-rising-specialty-drug-costs
#12
Katherine T Adams
No abstract text is available yet for this article.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23091434/ispot-d-trial-has-potential-to-personalize-antidepressant-treatment
#13
Bob Carlson
No abstract text is available yet for this article.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23091433/myriad-debate-over-gene-patents-continues
#14
Joanna T Brougher
No abstract text is available yet for this article.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23091432/drug-shortages-ease-but-have-we-gotten-to-the-root-of-the-problem
#15
John Carroll
No abstract text is available yet for this article.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23091431/will-comparative-effectiveness-research-finally-succeed
#16
Erwin A Blackstone, Joseph P Fuhr, Danielle Ziernicki
Autonomy, innovation, and drug access may be at stake along with personalized medicine. Can all stakeholders be satisfied and should cost be a factor?
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23091430/putting-oncology-patients-at-risk
#17
Bob Carlson
Using genomic tests to personalize oncology treatment is a worthy endeavor. But when the rush to capitalize on biomedical research overcomes the rules of evidence, it's the patients who suffer.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23091429/connecting-patients-with-specialty-products-part-2-the-future-of-specialty-drug-distribution
#18
Jack McCain
Previously, this series described distribution channels through which specialty drugs move to patients. This installment discusses changes and challenges that lie ahead, especially at the dispensing end.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23091428/showdown-in-steel-city
#19
Ed Silverman
Healthcare reform is encouraging the vertical integration of payers and providers. How far can this go in any one market before such efforts risk being deemed illegal? Pittsburgh provides a case study.
2012: Biotechnology Healthcare
https://www.readbyqxmd.com/read/23091427/asco-the-science-was-grand-but-what-will-payers-think
#20
Michael D Dalzell
No abstract text is available yet for this article.
2012: Biotechnology Healthcare
journal
journal
40998
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"